Total Payments
$807.47
2024 Payments
$583.95
Companies
4
Transactions
53
Medicare Patients
1,489
Medicare Billing
$163,332
Payment Breakdown by Category
Food & Beverage$807.47 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $807.47 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insulet Corporation | $371.16 | 17 | $0 (2024) |
| Novo Nordisk Inc | $259.91 | 27 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $157.82 | 8 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $18.58 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $583.95 | 41 | Insulet Corporation ($305.64) |
| 2023 | $133.87 | 7 | Insulet Corporation ($65.52) |
| 2022 | $89.65 | 5 | Novo Nordisk Inc ($48.26) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $23.20 | General |
| Category: Insulin Pump | ||||||
| 12/09/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $11.28 | General |
| Category: Insulin Pump | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.46 | General |
| Category: Insulin Pump | ||||||
| 11/05/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $22.83 | General |
| Category: Insulin Pump | ||||||
| 11/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $23.95 | General |
| Category: Insulin Pump | ||||||
| 10/22/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.40 | General |
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $28.69 | General |
| Category: Insulin Pump | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $0.81 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Endocrinology | ||||||
| 07/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: Insulin Pump | ||||||
| 05/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 386 | 1,398 | $253,990 | $55,217 |
| 2022 | 10 | 433 | 1,530 | $273,268 | $65,479 |
| 2021 | 8 | 372 | 633 | $73,240 | $25,606 |
| 2020 | 5 | 298 | 708 | $27,376 | $17,030 |
Total Patients
1,489
Total Services
4,269
Medicare Billing
$163,332
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 323 | $166,345 | $34,689 | 20.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 69 | 317 | $31,383 | $6,893 | 22.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 58 | 261 | $24,012 | $5,232 | 21.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 73 | 251 | $7,530 | $2,370 | 31.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 51 | 153 | $10,251 | $2,293 | 22.4% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 16 | 18 | $7,578 | $2,157 | 28.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 15 | $5,490 | $1,066 | 19.4% |
| 92250 | Photography of the retina | Office | 2023 | 16 | 33 | $1,212 | $429.86 | 35.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 20 | 27 | $189.00 | $86.67 | 45.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 83 | 360 | $173,160 | $39,714 | 22.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 73 | 454 | $39,498 | $9,435 | 23.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 70 | 261 | $24,273 | $5,923 | 24.4% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 27 | 39 | $15,561 | $4,594 | 29.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 80 | 265 | $7,950 | $2,503 | 31.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 52 | 101 | $6,262 | $1,567 | 25.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 12 | 13 | $4,433 | $1,130 | 25.5% |
| 95249 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | Office | 2022 | 12 | 12 | $1,884 | $524.58 | 27.8% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 12 | 12 | $156.00 | $46.72 | 29.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 12 | 13 | $91.00 | $41.94 | 46.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 63 | 92 | $42,688 | $11,272 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 48 | 48 | $6,273 | $5,302 | 84.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 44 | 155 | $13,020 | $3,485 | 26.8% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 121 | 228 | $5,155 | $2,773 | 53.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 11 | 11 | $1,814 | $1,542 | 85.0% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 19 | 27 | $2,430 | $625.30 | 25.7% |
About Launa Lister, NP
Launa Lister, NP is a Family healthcare provider based in Colville, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1679857833.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Launa Lister, NP has received a total of $807.47 in payments from pharmaceutical and medical device companies, with $583.95 received in 2024. These payments were reported across 53 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($807.47).
As a Medicare-enrolled provider, Lister has provided services to 1,489 Medicare beneficiaries, totaling 4,269 services with total Medicare billing of $163,332. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner, Nurse Practitioner
- Location Colville, WA
- Active Since 10/06/2011
- Last Updated 08/27/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1679857833
Products in Payments
- Omnipod (Device) $371.16
- t:slim X2 Insulin Pump with Control-IQ (Device) $157.82
- Ozempic (Drug) $121.82
- Rybelsus (Drug) $69.39
- GVOKE HYPOPEN (Drug) $18.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.